Birmingham, West Midlands -- (SBWIRE) -- 01/29/2014 -- Value Penny Stocks issues special report on Keryx Biopharmaceuticals (NASDAQ:KERX), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Prospect Capital Corporation (NASDAQ:PSEC), Star Scientific, Inc. (NASDAQ:STSI).
Keryx Biopharmaceuticals (NASDAQ:KERX) ended its recent business day with the gain of 5.10% and closed at the price of $15.87 after opening at $15.07. The stock traded during its last trading session with the total volume of 3,720,895 shares, as compared to its average volume of 3.14 million shares. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Will KERX Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) remained among the day advancers and traded with volume of 3,734,518 shares in the last session, as compared to average volume of 5.62 million shares. In comparison with 52 week range of $4.05 - $9.25, it faced lowest price of $6.86 during the last trading session whereas its day highest price was $7.15. The company’s total market capitalization is $1.52 billion, along with 218.57 million shares outstanding. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
Prospect Capital Corporation (NASDAQ:PSEC) showed 3,671,403 shares in volume during the last trading session, while the average trading volume remained 2.85 million shares. The stock kicked off its trading session at $11.15 and closed at $11.06. Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, and subordinated debt tranches of collateralized loan obligations, cash flow term loans, and bridge transactions.
Is PSEC Buy After The Recent Price Movement? Find Out Here
Star Scientific, Inc. (NASDAQ:STSI) stock traded during its last trading session with the total traded volume of 3,627,917 shares versus its average volume of 1.59 million shares. The company opened its trade at the price of $0.60 and its closing price was $0.731 after gaining 7.84% for the day. Star Scientific, Inc. engages in the development, manufacture, sale, and marketing of nutraceutical dietary supplements and consumer products. The company offers non-nicotine nutraceutical and dietary supplements.
Why Should Investors Buy STSI After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)